EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Management of Intraductal Carcinoma of the Prostate

Gabriel Wasinger, Olivier Cussenot iD, Eva Compérat

Cancers · 25.04.2024 · 16 (9) · 1650

DOI: 10.3390/cancers16091650 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.04.2024. Verfasst von Gabriel Wasinger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraductal carcinoma of the prostate (IDC-P) has emerged as a distinct entity with significant clinical implications in prostate cancer (PCa) management. Despite historically being considered an extension of invasive PCa, IDC-P shows unique biological characteristics that challenge traditional diagnostic and therapeutic settings. This review explores the clinical management of IDC-P. While the diagnosis of IDC-P relies on specific morphological criteria, its detection remains challenging due to inter-observer variability. Emerging evidence underscores the association of IDC-P with aggressive disease and poor clinical outcomes across various PCa stages. However, standardized management guidelines for IDC-P are lacking. Recent studies suggest considering adjuvant and neoadjuvant therapies in specific patient cohorts to improve outcomes and tailor treatment strategies based on the IDC-P status. However, the current level of evidence regarding this is low. Moving forward, a deeper understanding of the pathogenesis of IDC-P and its interaction with conventional PCa subtypes is crucial for refining risk stratification and therapeutic interventions.

Schlagwörter

Stichwörter der Autor:innen

intraductal carcinomapathological risk factorsprostate cancertreatment implication

Autor:innen und Institutionen

  • Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Urology, Medical University of Vienna, 1090 Vienna, Austria.

ORCID-Profile: Olivier Cussenot

Zitieren

APA

Wasinger, G., Cussenot, O., & Compérat, E. (2024). Clinical Management of Intraductal Carcinoma of the Prostate. Cancers, 16(9), 1650. https://doi.org/10.3390/cancers16091650

Vancouver

Wasinger G, Cussenot O, Compérat E. Clinical Management of Intraductal Carcinoma of the Prostate. Cancers. 2024;16(9):1650. doi:10.3390/cancers16091650

BibTeX
@article{Wasinger2024,
  author = {Wasinger, Gabriel and Cussenot, Olivier and Compérat, Eva},
  title = {Clinical Management of Intraductal Carcinoma of the Prostate},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1650},
  doi = {10.3390/cancers16091650}
}
Kostenlos starten →